OTC Markets EXMKT - Delayed Quote USD

Tengjun Biotechnology Corp. (TJBH)

2.0000
0.0000
(0.00%)
At close: May 9 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Total Revenue
103,078.8080
150,136.7380
0
0.2900
Cost of Revenue
6,445.1460
9,722.3410
0
0.0580
Gross Profit
96,633.6620
140,414.3970
0
0.2320
Operating Expense
85,376.4990
124,350.2610
738.2340
666.6770
Operating Income
11,257.1630
16,064.1360
-738.2340
-666.4450
Net Non Operating Interest Income Expense
36.9010
22.8900
-4.9700
-15.1020
Other Income Expense
-861.8270
-805.4210
-4.3210
-9.3390
Pretax Income
10,432.2370
15,281.6050
-747.5250
-690.8860
Tax Provision
2,903.2920
3,309.9310
0
0
Net Income Common Stockholders
7,116.4300
11,346.8410
-747.5250
-690.8860
Diluted NI Available to Com Stockholders
7,116.4300
11,346.8410
-747.5250
-690.8860
Basic EPS
0.08
0.14
-0.04
-0.04
Diluted EPS
0.08
0.14
-0.04
-0.04
Basic Average Shares
96,645.2500
80,170.3450
20,294.4470
19,285.7140
Diluted Average Shares
96,645.2500
80,170.3450
20,294.4470
19,285.7140
Total Operating Income as Reported
11,257.1630
16,064.1360
-738.2340
-666.4450
Total Expenses
91,821.6450
134,072.6020
738.2340
666.7350
Net Income from Continuing & Discontinued Operation
7,116.4300
11,346.8410
-747.5250
-690.8860
Normalized Income
7,116.4300
11,346.8410
-747.5250
-690.8860
Interest Expense
--
--
4.9700
15.1020
Net Interest Income
36.9010
22.8900
-4.9700
-15.1020
EBIT
11,257.1630
16,064.1360
-738.2340
-675.7840
EBITDA
11,257.1630
16,373.0220
-419.7890
-402.6790
Reconciled Cost of Revenue
6,445.1460
9,722.3410
0
0.0580
Reconciled Depreciation
-146.6320
308.8860
318.4450
273.1050
Net Income from Continuing Operation Net Minority Interest
7,116.4300
11,346.8410
-747.5250
-690.8860
Normalized EBITDA
11,257.1630
16,373.0220
-419.7890
-402.6790
Tax Rate for Calcs
0.0003
0.0002
0
0
Tax Effect of Unusual Items
0
0
0
0
12/31/2020 - 5/28/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

GUZOF Grupo Herdez, S.A.B. de C.V.
2.9000
0.00%
 
FPAFY First Pacific Company Limited
3.5200
-0.85%
 
NAII Natural Alternatives International, Inc.
3.2300
+1.89%
 
BTTR SRx Health Solutions Inc.
2.1200
+8.72%
 
RKDA Arcadia Biosciences, Inc.
3.8791
-8.30%
 
WEST Westrock Coffee Company
7.26
+18.05%
 
BRFS BRF S.A.
3.3800
-5.85%
 
CLNN Clene Inc.
2.6300
+1.94%
 
CDXC Niagen Bioscience, Inc.
7.87
-0.88%
 
ORIS Oriental Rise Holdings Limited
0.9010
+1.77%